Susceptibility breakpoints
Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis
9
Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community acquired respiratory tract infections?
9
Normalized Resistance Interpretation as a Tool for Establishing Epidemiological MIC Susceptibility Breakpoints
8
Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed
7
Nationwide German Multicenter Study on Prevalence of Antibiotic Resistance in Staphylococcal Bloodstream Isolates and Comparative In Vitro Activities of Quinupristin Dalfopristin
5
Clinical Outcomes of Enterobacteriaceae Infections Stratified by Carbapenem MICs
5
Evaluation of Updated Interpretative Criteria for Categorizing Klebsiella pneumoniae with Reduced Carbapenem Susceptibility
9
Effect of the 2014 Clinical and Laboratory Standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospital
6
Antimicrobial susceptibility of strains of Enterobacteriaceae isolated from bloodstream infections using current CLSI and EUCAST breakpoints
5
Susceptibility of Extended Spectrum β Lactamase Producing Enterobacteriaceae According to the New CLSI Breakpoints
5
Don't Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa
11
Fluoroquinolone Susceptibility Testing of Salmonella enterica: Detection of Acquired Resistance and Selection of Zone Diameter Breakpoints for Levofloxacin and Ofloxacin
8
Breakpoints for Predicting Pseudomonas aeruginosa Susceptibility to Inhaled Tobramycin in Cystic Fibrosis Patients: Use of High Range Etest Strips
6
Molecular characterization of the breakpoints of an inversion fixed between Drosophila melanogaster and D. subobscura.
6
VetCAST method for determination of the pharmacokineticpharmacodynamic cut-off values of a long-acting formulation of florfenicol to support clinical breakpoints for florfenicol Antimicrobial Susceptibility Testing in cattle
10
Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls
7
Identification of Potential Recombination Breakpoints in Human Parechoviruses
5
Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard
7
THE ECCENTRICITY OF VERMILION DEFICIENCIES IN DROSOPHILA MELANOGASTER
12
Inability of cephalothin testing to predict cefprozil susceptibility
5